These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 4181510)

  • 1. Studies on the antigen reacting with the thyroid-stimulating immunoglobulin (LATS) in thyrotoxicosis.
    Benhamou-Glynn N; el-Kabir DJ; Roitt IM; Doniach D
    Immunology; 1969 Feb; 16(2):187-204. PubMed ID: 4181510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evolution of immunoglobulins IgA, IgM, IgG and LATS during treatment of hyperthyroidism with carmibazole and radioiodine].
    Mahaux JE; Delcourt R; Nagel M; Chamla-Soumenkoff J; Levin S
    Ann Endocrinol (Paris); 1970; 31(2):314-23. PubMed ID: 4192759
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum immunoglobulin levels in thyroid disease.
    Glynne A; Thomson JA
    Clin Exp Immunol; 1972 Sep; 12(1):71-8. PubMed ID: 4628405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the immunological properties of LATS.
    Ochi Y; DeGroot LJ
    Endocrinology; 1968 Oct; 83(4):845-54. PubMed ID: 4176638
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-acting thyroid stimulator (LATS) and long acting thyroid stimulator protector (LATS-P) in untreated thyrotoxicosis.
    Hardisty CA; Hanford L; Humphries H; Munro DS
    Clin Endocrinol (Oxf); 1981 Jun; 14(6):631-9. PubMed ID: 6895353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological studies on human thyroid glands, especially on antigenicity of epithelial cells in various diseases.
    Kawamura N
    Bull Tokyo Med Dent Univ; 1969 Dec; 16(4):311-25. PubMed ID: 4192196
    [No Abstract]   [Full Text] [Related]  

  • 7. Transient thyrotoxicosis in an infant delivered to a long-acting thyroid stimulator (LATS)- and LATS protector-negative, thyroid-stimulating antibody-positive woman with Hashimoto's thyroiditis.
    Hoffman WH; Sahasrananan P; Ferandos SS; Burek CL; Rose NR
    J Clin Endocrinol Metab; 1982 Feb; 54(2):354-6. PubMed ID: 6119322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific and nonspecific responses in the bioassay of long-acting thyroid stimulator (LATS).
    Chopra IJ; Solomon DH; Limberg NP
    J Clin Endocrinol Metab; 1970 Oct; 31(4):382-90. PubMed ID: 5468701
    [No Abstract]   [Full Text] [Related]  

  • 9. [Thyroid-stimulating antibodies].
    Kandror VI; Ibragim MD
    Probl Endokrinol (Mosk); 1985; 31(4):75-80. PubMed ID: 2864686
    [No Abstract]   [Full Text] [Related]  

  • 10. [Long-acting thyroid stimulator (LATS) in thyroid gland diseases and its relationship to the thyroid gland antibodies].
    Weissbecker L; Uthgenannt H; Schemmel K; Müller W; Heesen H; Eickenbusch W; Bindeballe W
    Schweiz Med Wochenschr; 1967 Jul; 97(28):898-904. PubMed ID: 5587446
    [No Abstract]   [Full Text] [Related]  

  • 11. LATS protector, the human thyroid stimulator.
    Adams DD
    N Z Med J; 1975 Jan; 81(531):22-3. PubMed ID: 1055310
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunologic problems in thyroid diseases].
    Höfer R; Schatz H
    Z Gesamte Inn Med; 1969 Mar; 24(6):Suppl:91-6 c. PubMed ID: 5802036
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunoglobulin levels and long-acting thyroid stimulator (LATS) in hyperthyroidism. A preliminary study.
    Yamakido M; Yokoyama M; Noguchi S
    Hawaii Med J; 1969; 29(2):118-9. PubMed ID: 5361480
    [No Abstract]   [Full Text] [Related]  

  • 14. Evidence to suggest that LATS protector stimulates the human thyroid gland.
    Adams DD; Kennedy TH
    J Clin Endocrinol Metab; 1971 Jul; 33(1):47-51. PubMed ID: 5558041
    [No Abstract]   [Full Text] [Related]  

  • 15. Long-acting thyroid stimulator in euthyroid relatives of thyrotoxic patients.
    Wall JR; Good BF; Hetzel BS
    Lancet; 1969 Nov; 2(7629):1024-6. PubMed ID: 4187540
    [No Abstract]   [Full Text] [Related]  

  • 16. The long-acting thyroid stimulator.
    Munro DS
    Sci Basis Med Annu Rev; 1970; ():21-30. PubMed ID: 4920180
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis.
    Adams DD; Kennedy TH; Stewart RD
    Br Med J; 1974 Apr; 2(5912):199-201. PubMed ID: 4406686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Experimental production of a thyroid-stimulating antithyroid antibody.
    McKenzie JM
    J Clin Endocrinol Metab; 1968 May; 28(5):596-602. PubMed ID: 4172455
    [No Abstract]   [Full Text] [Related]  

  • 19. Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies.
    Mori T; Fisher J; Kriss JP
    J Clin Endocrinol Metab; 1970 Aug; 31(2):119-33. PubMed ID: 4193195
    [No Abstract]   [Full Text] [Related]  

  • 20. LATS-protector activity in thyrotoxicosis measured by thyroidal intracellular colloid droplet formation.
    Shishiba Y; Miyachi Y; Takaishi M; Ozawa Y
    J Clin Endocrinol Metab; 1978 May; 46(5):841-8. PubMed ID: 262769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.